As a Vice President of Investments, Brendan is responsible for the origination, underwriting, and closing of investment opportunities made on behalf of Davis’ value-add investment funds. Brendan specializes in the life sciences and high intellectual office sector throughout the United States. Since joining Davis, Brendan has supported the company’s expansion of its life science portfolio with significant transactions including Charles Park, a 405,000 RSF lab redevelopment in East Cambridge, MA and 66 Galen Street, a 224,000 RSF lab development in Watertown, MA.
Prior to joining Davis in 2019, Brendan closed more than $7.1 billion in investment sale, structured equity, and financing transactions while at HFF, L.P. in New York City and Eastdil Secured in Boston. Brendan began his career on the acquisition & leasing team at BioMed Realty Trust.
Brendan holds a Bachelor of Arts Degree with a concentration in Classics from The College of the Holy Cross and is a graduate of Noble & Greenough in Dedham, MA.